NCT01885065|Completed
Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients
Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients
Loading search results
Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients
Sponsor study identifier
interventional
25
1 country
1
Study Start
July 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2012
Actual (reported)Study Completion
December 2012
Actual (reported)The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2012
Date type not reportedThis date has not been verified as actual or estimated.
September 2012
Actual (reported)December 2012
Actual (reported)June 16, 2013
Actual (reported)June 24, 2013
Actual (reported)Changes in subjective dry mouth score
The outcome measure (subjective dry mouth score) will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)
baseline, 2 weeks and 4 weeks after intervention
Changes in objective dry mouth score
Baseline, 2 week and 4 weeks after the start date
Changes in salivary pH
Baseline, 2 weeks and 4 weeks after the start date
Changes in salivary buffering capacity
Baseline, 2 weeks and 4 weeks after the start date
Continuous oral intake of edible gel-based artificial saliva (30-50 ml/day) for four weeks
Gel-based artificial saliva is an edible non-nutritious gel intended to relieve dry mouth. Taking orally 1-2 teaspoon each time, 5 times / day (30-50 ml/ day) for four weeks.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Mahavachiralongkorn cancer hospital
Pathum Thani, Changwat Pathum Thani, 12110, Thailand
Aroonwan Lam-ubol, DDS, PhD
Faculty of Dentistry, Srinakharinwirot University
25 participants (actual enrollment reported by the registry).
First Submitted
June 16, 2013
First Posted
June 24, 2013
Study Start
July 2012
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
September 2012
Actual (reported)Study Completion
December 2012
Actual (reported)Last Updated
June 24, 2013
Record last verified: 2013-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: